Hazard Ratio

Individuals with achalasia show a higher risk for mortality than matched reference individuals from the general population, new research shows.

Researchers used digital polymerase chain reaction assays to measure BRAF V600E or BRAF V600K circulating tumor DNA in patients with resected melanoma.

Innovative polatuzumab vedotin plus R-CHP therapy reshapes treatment of older adult patients with diffuse large B-cell lymphoma.

Tapering schedule makes a difference in uveitis recurrence risk, study finds

Emerging data suggest that SBRT may be comparable with surgery for definitive treatment of stage I NSCLC in certain patients. When is one approach preferred and in whom?

Better 3-year survival and fewer recurrences, surgical complications, and adverse events

Acute pancreatitis is linked to increased mortality after hospital discharge, with the elevated mortality rate persisting for over 10 years, according to a recent study.

A large population-based cohort study reports that using GLP-1 RAs significantly reduces the risk for cardiovascular events and mortality in patients with MASLD.

A study of Danish men reveals that the use of anabolic androgenic steroids is associated with a substantial increase in the risk for multiple cardiovascular diseases.

Impairment in distinguishing spoken words from background noise may up Parkinson's risk by 57% per 10 dB increase in the speech reception threshold, new research suggests.

Daily low-dose aspirin reduced the risk for colorectal cancer recurrence by roughly half in patients with mutations in the PIK3 signaling pathway.

Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or mpMRI-staged care.

Most women with intermediate-risk breast cancer can safely skip chest wall irradiation after mastectomy and avoid the risks for chest wall pain, fibrosis, heart damage, and lung cancer.

"Incredible" results from the PATINA trial suggested a new standard of care for HER2, ER-positive metastatic breast cancer.

Achieving remission and addressing CV risk factors made a big difference in Greek study

A cohort study identified a link between COVID-19 and a faster decline in kidney function, especially following hospitalization, in contrast to pneumonia.

New research suggested the monoclonal antibody may help ward off progression to myeloma or death.

Outside experts say, however, that the choice of control group in the trial may limit the relevance to clinical practice.

Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal carcinoma in situ.

Case-control study reinforces connection between inflammation and HFpEF